FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care (DG48)Product type:GuidanceProgramme:Diagnostics guidancePublished: 7 June 2023
MRI-based technologies for assessing non-alcoholic fatty liver disease (DG50)Product type:GuidanceProgramme:Diagnostics guidancePublished: 12 January 2023
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver (DG5)Product type:GuidanceProgramme:Diagnostics guidancePublished: 29 August 2012
LIVERFASt for diagnosing and staging liver injury and chronic liver disease, (MT783)Status:Topic selectionProgramme:Diagnostics guidanceExpected publication date: TBC